Non-Apoptotic Programmed Cell Death in Thyroid Diseases

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2022 Dec 23

PMID 36559016

Authors

Feihong Ji

Xinguang Qiu

Affiliations

Soon will be listed here.

Abstract

Thyroid disorders are among the most common endocrinological conditions. As the prevalence of thyroid diseases increases annually, the exploration of thyroid disease mechanisms and the development of treatments are also gradually improving. With the gradual advancement of therapies, non-apoptotic programmed cell death (NAPCD) has immense potential in inflammatory and neoplastic diseases. Autophagy, pyroptosis, ferroptosis, and immunogenic cell death are all classical NAPCD. In this paper, we have compiled the recent mechanistic investigations of thyroid diseases and established the considerable progress by NAPCD in thyroid diseases. Furthermore, we have elucidated the role of various types of NAPCD in different thyroid disorders. This will help us to better understand the pathophysiology of thyroid-related disorders and identify new targets and mechanisms of drug resistance, which may facilitate the development of novel diagnostic and therapeutic strategies for patients with thyroid diseases. Here, we have reviewed the advances in the role of NAPCD in the occurrence, progression, and prognosis of thyroid diseases, and highlighted future research prospects in this area.

References

Li D, Zhang Y, Xu H, Zhang X . The role of BRAF in the pathogenesis of thyroid carcinoma. Front Biosci (Landmark Ed). 2015; 20(7):1068-78. DOI: 10.2741/4359. View

Pastwinska J, Karas K, Karwaciak I, Ratajewski M . Targeting EGFR in melanoma - The sea of possibilities to overcome drug resistance. Biochim Biophys Acta Rev Cancer. 2022; 1877(4):188754. DOI: 10.1016/j.bbcan.2022.188754. View

Hirota K, Miyoshi T, Kugou K, Hoffman C, Shibata T, Ohta K . Stepwise chromatin remodelling by a cascade of transcription initiation of non-coding RNAs. Nature. 2008; 456(7218):130-4. DOI: 10.1038/nature07348. View

Cetti E, Di Marco T, Mauro G, Mazzoni M, Lecis D, Minna E . Mitosis perturbation by MASTL depletion impairs the viability of thyroid tumor cells. Cancer Lett. 2018; 442:362-372. DOI: 10.1016/j.canlet.2018.11.010. View

Valencia M, Kim S, Jang Y, Lee S . Neuronal Autophagy: Characteristic Features and Roles in Neuronal Pathophysiology. Biomol Ther (Seoul). 2021; 29(6):605-614. PMC: 8551733. DOI: 10.4062/biomolther.2021.012. View

Speeckaert M, Speeckaert R, Wierckx K, Delanghe J, Kaufman J . Value and pitfalls in iodine fortification and supplementation in the 21st century. Br J Nutr. 2011; 106(7):964-73. DOI: 10.1017/S000711451100273X. View

Yu Y, Hou L, Song H, Xu P, Sun Y, Wu K . Akt/AMPK/mTOR pathway was involved in the autophagy induced by vitamin E succinate in human gastric cancer SGC-7901 cells. Mol Cell Biochem. 2016; 424(1-2):173-183. DOI: 10.1007/s11010-016-2853-4. View

Waters S, Marchbank K, Solomon E, Whitehouse C . Autophagic receptors Nbr1 and p62 coregulate skeletal remodeling. Autophagy. 2010; 6(7):981-3. DOI: 10.4161/auto.6.7.13155. View

Sun W, Qian K, Guo K, Chen L, Xiang J, Li D . LHPP inhibits cell growth and migration and triggers autophagy in papillary thyroid cancer by regulating the AKT/AMPK/mTOR signaling pathway. Acta Biochim Biophys Sin (Shanghai). 2020; 52(4):382-389. DOI: 10.1093/abbs/gmaa015. View

10.

Yu S, Medling B, Yagita H, Braley-Mullen H . Characteristics of inflammatory cells in spontaneous autoimmune thyroiditis of NOD.H-2h4 mice. J Autoimmun. 2001; 16(1):37-46. DOI: 10.1006/jaut.2000.0458. View

11.

Wang Y, Wei Z, Pan K, Li J, Chen Q . The function and mechanism of ferroptosis in cancer. Apoptosis. 2020; 25(11-12):786-798. DOI: 10.1007/s10495-020-01638-w. View

12.

Leung A, Braverman L . Consequences of excess iodine. Nat Rev Endocrinol. 2013; 10(3):136-42. PMC: 3976240. DOI: 10.1038/nrendo.2013.251. View

13.

Shi X, Li C, Tan L, Wen S, Liao T, Zhang Y . Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3, and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study. J Clin Endocrinol Metab. 2020; 106(1):120-132. DOI: 10.1210/clinem/dgaa701. View

14.

Colin I, Denef J, Lengele B, Many M, Gerard A . Recent insights into the cell biology of thyroid angiofollicular units. Endocr Rev. 2013; 34(2):209-38. PMC: 3610675. DOI: 10.1210/er.2012-1015. View

15.

Crispo F, Notarangelo T, Pietrafesa M, Lettini G, Storto G, Sgambato A . BRAF Inhibitors in Thyroid Cancer: Clinical Impact, Mechanisms of Resistance and Future Perspectives. Cancers (Basel). 2019; 11(9). PMC: 6770736. DOI: 10.3390/cancers11091388. View

16.

Chen F, Yang D, Wang S, Che X, Wang J, Li X . Livin regulates prostate cancer cell invasion by impacting the NF-κB signaling pathway and the expression of FN and CXCR4. IUBMB Life. 2012; 64(3):274-83. DOI: 10.1002/iub.606. View

17.

Meng X, Wang H, Zhao J, Hu L, Zhi J, Wei S . Apatinib Inhibits Cell Proliferation and Induces Autophagy in Human Papillary Thyroid Carcinoma via the PI3K/Akt/mTOR Signaling Pathway. Front Oncol. 2020; 10:217. PMC: 7078169. DOI: 10.3389/fonc.2020.00217. View

18.

Yang X, Yang L, Wu J, Guo M, Zhang Y, Ma S . Treatment of lidocaine on subacute thyroiditis via restraining inflammatory factor expression and inhibiting pyroptosis pathway. J Cell Biochem. 2019; 120(7):10964-10971. DOI: 10.1002/jcb.27675. View

19.

Guan H, Ji M, Bao R, Yu H, Wang Y, Hou P . Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer. J Clin Endocrinol Metab. 2009; 94(5):1612-7. DOI: 10.1210/jc.2008-2390. View

20.

Wu Y, Zhang J, Li Q . Autophagy, an accomplice or antagonist of drug resistance in HCC?. Cell Death Dis. 2021; 12(3):266. PMC: 7954824. DOI: 10.1038/s41419-021-03553-7. View